Início › Câncer de Próstata › Washington

Ensaios clínicos de Câncer de Próstata em Washington

51 estudos para Câncer de Próstata estão buscando participantes em locais em Washington.

Cidades em Washington

Texto oficial do estudo (Inglês)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

University of Washington, Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
e mais 19

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Valley Medical Center, Renton

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

Swedish Medical Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 28 de set. de 2026 · NCT06095089

Precision-Based Genomics in Prostate Cancer

University of Washington, Seattle

RecrutandoEstudo observacional

Idades de 18 a 120 · Homens · Atualizado em 28 de set. de 2026 · NCT04706663

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

Fred Hutchinson Cancer Research Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT06801236

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Spokane Urology ( Site 0035), Spokane

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06136650

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 25 de set. de 2026 · NCT07082920

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Northwest Medical Specialties, PLLC, Bonney Lake
Northwest Medical Specialties, PLLC, Federal Way
Northwest Medical Specialties, PLLC, Gig Harbor
e mais 2

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 24 de set. de 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Fred Hutchinson Cancer Research Center, Seattle

RecrutandoFase 2/3

Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06780670

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Northwest Medical Specialties, PLLC, Tacoma

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 22 de set. de 2026 · NCT07213674

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Swedish Medical Center, Seattle
Northwest Medical Specialties, Tacoma

RecrutandoFase 3

Idades de 18 a 100 · Homens · Atualizado em 22 de set. de 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

VA Puget Sound Health Care System ( Site 0054), Seattle
Fred Hutchinson Cancer Center ( Site 0060), Seattle

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 17 de set. de 2026 · NCT06925737

PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness

University of Washington Medical Center, Seattle

RecrutandoEstudo observacional

Idades 18 e acima · Homens · Atualizado em 15 de set. de 2026 · NCT04995198

The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

University of Washington, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 14 de set. de 2026 · NCT06111781

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

PeaceHealth Saint Joseph Medical Center, Bellingham
Fred Hutchinson Cancer Center, Seattle
FHCC at Northwest Hospital, Seattle
e mais 1

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05946213

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Investigational Site Number: 400, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 10 de set. de 2026 · NCT05997615

Prostate Active Surveillance Study

Veterans Affairs Puget Sound Health Care System, Seattle
University of Washington, Seattle

RecrutandoEstudo observacional

Idades 21 e acima · Homens · Atualizado em 2 de set. de 2026 · NCT00756665

The Vanguard Study: Testing a New Way to Screen for Cancer

Madigan Army Medical Center, Tacoma

RecrutandoVoluntários saudáveis bem-vindos

Idades de 45 a 75 · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06995898

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 27 de ago. de 2026 · NCT07698535

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Research Site, Tacoma

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 26 de ago. de 2026 · NCT07611110

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 25 de ago. de 2026 · NCT05593497

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

University of Washington Medical Center, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 24 de ago. de 2026 · NCT07745361

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 21 de ago. de 2026 · NCT06844383

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 21 de ago. de 2026 · NCT04221542

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

Providence Regional Cancer System-Aberdeen, Aberdeen
PeaceHealth Saint Joseph Medical Center, Bellingham
Providence Regional Cancer System-Centralia, Centralia
e mais 19

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 19 de ago. de 2026 · NCT04423211

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center, Seattle
Northwest Medical Specialties, PLLC - Tacoma, Tacoma

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 17 de ago. de 2026 · NCT06842498

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 14 de ago. de 2026 · NCT04812366

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoEstudo observacional

Idades 18 e acima · Homens · Atualizado em 12 de ago. de 2026 · NCT04489719

Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 1/2

Idades 18 e acima · Homens · Atualizado em 11 de ago. de 2026 · NCT06236139

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 10 de ago. de 2026 · NCT06067841

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

Todas as idades · Homens · Atualizado em 6 de ago. de 2026 · NCT06145633

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades 18 e acima · Homens · Atualizado em 6 de ago. de 2026 · NCT01050504

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 31 de jul. de 2026 · NCT06613100

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

Fred Hutch/University of Washington Cancer Consortium, Seattle

RecrutandoFase 2

Idades 18 e acima · Homens · Atualizado em 21 de jul. de 2026 · NCT06039371

Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial

Fred Hutch/University of Washington Cancer Consortium, Seattle

Recrutando

Idades 18 e acima · Homens · Atualizado em 15 de jul. de 2026 · NCT05918263

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Providence Regional Cancer System-Aberdeen, Aberdeen
FHCC Overlake, Bellevue
PeaceHealth Saint Joseph Medical Center, Bellingham
e mais 22

RecrutandoFase 3

Idades 18 e acima · Homens · Atualizado em 14 de jul. de 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

University of Washington, Fred Hutchinson Cancer Center, Seattle

RecrutandoFase 1

Idades 18 e acima · Homens · Atualizado em 9 de jul. de 2026 · NCT05413421

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.